GlassScriptPhysician profile
Indu S Anand
NPI 1790773695
$1,108.68
in general payments reported to CMS, 2019-2025
18 companies · $268 in 2025
The $268 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $186 · 2020: $81.10 · 2021: $72.28 · 2022: $255 · 2023: $77.59 · 2024: $169 · 2025: $268.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $514.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $514.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exeltis, USA INC. | $164.94 | 2020-2025 | Slynd |
| Abbvie INC. | $153.78 | 2019-2024 | Lo Loestrin Fe |
| Mayne Pharma Commercial LLC | $126.88 | 2022-2025 | |
| Avion Pharmaceuticals | $106.62 | 2019-2021 | |
| Roche Diagnostics Corporation | $94.77 | 2019 | |
| Aspira Women'S Health INC | $93.13 | 2022 | |
| Organon LLC | $90.97 | 2022-2025 | Nexplanon |
| Astellas Pharma US INC | $58.80 | 2023-2025 | Veozah |
| Optumhealth Care Solutions, LLC | $54.83 | 2025 | Eitan Medical, Vivify Health Care Team Portal 001 |
| Mission Pharmacal Company | $26.62 | 2019 | |
| Pfizer INC. | $23.46 | 2024 | |
| Hydrofera LLC | $19.15 | 2025 | Cutimed Sorbion |
| Coopersurgical, INC. | $18.48 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $18.47 | 2021 | |
| Novo Nordisk INC | $15.61 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $14.92 | 2023 | Myfembree |
| Mylan Pharmaceuticals INC. | $14.78 | 2019 | |
| Amag Pharmaceuticals, INC. | $12.47 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Indu Anand listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.